GEMINI THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Merger of Gemini Therapeutics, Inc. – GMTX


NEW ORLEANS, Sept. 21, 2022 /PRNewswire/ — Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Gemini Therapeutics, Inc. (NasdaqGM: GMTX) with Disc Medicine, Inc. pursuant to which Gemini shareholders will end up owning approximately 28% of the combined company, subject to adjustment. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger undervalues the Company.

If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com

) toll free at any time at 855-768-1857, or visit  https://www.ksfcounsel.com/cases/nasdaqgm-gmtx/ to learn more.

To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.

Kahn Swick & Foti, LLC

1100 Poydras St., Suite 3200

New Orleans, LA 70163

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/gemini-therapeutics-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick–foti-llc-investigates-merger-of-gemini-therapeutics-inc—gmtx-301630318.html

SOURCE Kahn Swick & Foti, LLC

rt

Source link

The content is by PR Newswire. Headlines of Today Media is not responsible for the content provided or any links related to this content. Headlines of Today Media is not responsible for the correctness, topicality or the quality of the content.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy